Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)

R. du Bois, C. Albera, W. Bradford, U. Costabel, A. Kartashov, P. Noble, J. Szwarcberg, D. Valeyre, D. Weycker, T. King (Denver, Brisbane, Brookline, Durham, San Francisco, United States Of America; Turin, Italy; Essen, Germany; Paris, France)

Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Session: Clinical issues in idiopathic pulmonary fibrosis
Session type: Oral Presentation
Number: 3632
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. du Bois, C. Albera, W. Bradford, U. Costabel, A. Kartashov, P. Noble, J. Szwarcberg, D. Valeyre, D. Weycker, T. King (Denver, Brisbane, Brookline, Durham, San Francisco, United States Of America; Turin, Italy; Essen, Germany; Paris, France). Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF). Eur Respir J 2010; 36: Suppl. 54, 3632

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Analysis of patients with idiopathic pulmonary fibrosis (IPF) with percent predicted forced vital capacity (FVC)<50% treated with pirfenidone (PFD) in RECAP
Source: International Congress 2016 – IPF treatment I
Year: 2016



Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Post-bronchodilator response (PBDR) evaluated by plethysmographic and spirometric target parameters in patients with COPD, asthma-COPD-overlap (ACO) and asthma
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018



The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013

Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012


Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Is the forced expiratory volume in 6 seconds (FEV6) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients
Source: Eur Respir J 2001; 18: Suppl. 33, 13s
Year: 2001

Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Application and interpretation in RCT's
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001

FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015

How reliable is total lung capacity (TLC) measured during single breath (SB) diffusion capacity test (DLCO) comparing to plethysmography (PL) method in diabetic subjects with normal lung function?
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019
Year: 2020